As shown in Figure 1, Cant exerts its inhibitory effect on NLRP3 inflammasome formation in RA by suppressing NF-κB activation, downregulating NLRP3, pro-IL-1β, and pro-IL-18 expression, and reducing ROS production, thereby preventing pyroptosis. Here, IL18 is linked to rheumatoid arthritis.